期刊文献+

雌激素与去卵巢小鼠外周血T淋巴细胞亚群及免疫球蛋白关系的研究 被引量:4

Effect of estradiol replacement on levels of peripheral blood T cell subsets and immunoglobulin in ovariectomized mice
下载PDF
导出
摘要 目的 通过对去卵巢小鼠补充E2治疗,观察外周血T淋巴细胞亚群及免疫球蛋白水平变化,探讨E2对上述指标的影响.方法 60只健康雌性小鼠随机分为3组,假手术组不给药物,去卵巢小鼠分别接受苯甲酸雌二醇(用药组)及注射油(非用药组)皮下注射治疗,每周2次,共注射25次(12周),酶联免疫吸附法检测3组血清E2及免疫球蛋白(IgG、IgM、IgA)水平,流式细胞仪检测血CD4+ T细胞和CD8+T细胞变化.结果 (1)术后12 周用药组血CD8+T细胞数(18.16±4.04)比非用药组(25.73±3.63)降低(P<0.05);假手术组血CD8+T细胞数(16.54±3.12)比非用药组(25.73±3.63)降低(P<0.05),差异有统计学意义.(2)与非用药组比较,用药组及假手术组CD4+ T细胞数呈上升趋势,但差异均无统计学意义(均P >0.05).(3)血清IgG、IgM、IgA水平3组比较差异均无统计学意义(均P >0.05).结论 E2可降低去卵巢小鼠外周血CD8+T细胞水平,参与免疫系统调节. Objective To investigate the relationship between estradiol ( E2)and the levels of peripheral T cell subsets and immunoglobulins in ovariectomized mice. Methods Sixty female mice were divided into 3 group at random: sham operation group, OVX+EB group and OVX group. In OVX+EB group ovariectomized mice were injected with estradiol twice a week for 25 times, in OVX group ovariectomized mice were treated with injection oil instead. The serum levels of E2 and immunoglobulin G, M, A were measured by ELISA; peripheral blood CD4+ and CD8+levels were measured by flow cytometer. Results The CD8+ levels in OVX+EB group and sham group were significantly lower than those in OVX group ( 18.16 ± 4.04 and 16.54 ± 3.12vs 25.73 ± 3.63, both P〈0.05). There were no differences in CD4+ levels and immunoglobulin (G,M,A)levels among three group. Conclusion E2 can decrease the peripheral blood CD8+levels in ovariectomized mice.
出处 《浙江医学》 CAS 2011年第12期1793-1795,共3页 Zhejiang Medical Journal
基金 金华市科技局项目(J2008-3-030)
关键词 去卵巢 雌激素 T淋巴细胞 免疫球蛋白 Ovariectomize Estradiol T lymphocyte Immunoglobulin
  • 相关文献

参考文献11

  • 1Verthelyi D,Ansar A S.Characterization of estrogen induce autoantibodies to cardioliPin in autoimmune mice[J].J Autoimmune,2003,10:115-125.
  • 2Caroine C,Whiacre.Sex differences in autoimmune disease[J].Nature,2001,11:777-780.
  • 3Kjaergaard A D,Ellervik C,Tybjaerg-Hansen A,et al.Estrogen recePtor alPha PolymorPhism and risk of cardiovascular disease,cancer,and hiP fracture:cross-sectional,cohort,and case-controlstudies and a meta-analysis[J].Circulation,2007,115:861-871.
  • 4Kumru S,Godekmerdan A,Yilmaz B,et al.mmune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women[J].J Reprod Immunol,2004,63(1):31-38.
  • 5Pierdominici M,Maselli A,Colasanti T,et al.Estrogen receptor profiles in human peripheral blood lymphocytes[J].Immunol Lett,2010,132(1-2):79-85.
  • 6Phiel K L,Henderson R A,Adelman S J,et al.Differential estrogen recePtor gene exPression in human PeriPheral blood mononuclear cell PoPulations[J].Immunol Lett,2005,97:107-113.
  • 7Erlandsson M C,Jonsson C A,Islander U,et al.Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice[J].Immunology,2003,108:346-351.
  • 8夏贤,张绍芬,刘瑞梓,陈珣,刘康达.口服和经皮肤途径雌激素替代治疗对手术绝经妇女围绝经症状和T淋巴细胞雌激素受体亚型表达的影响[J].生殖医学杂志,2009,18(2):101-106. 被引量:4
  • 9Xia X,Zhang S,Yu Y,et al.Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women[J].J Reprod Immunol,2009,81(1):89-96.
  • 10Zen M,Ghirardello A,Iaccarino L,et al.Hormones,immune response,and pregnancy in healthy women and SLE patients[J].Swiss Med Wkly,2010,140(13-14):187-201.

二级参考文献18

  • 1The Executive Committee of IMS. Guidelines for the hor mone treatment of women in the menopausal transition and beyond[J].Maturitas, 2005, 51(1): 15-20.
  • 2Phiel KL, Henderson RA, Adelman SJ, et al. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations[J]. Immunol Lett, 2005, 97 (1), 107-113.
  • 3Rider V, Li X, Peterson G, et al. Differential expression of estrogen receptors in women with systemic lupus erythematosus[J]. J Rheumatol, 2006, 33(6): 1093-1101.
  • 4Kupperman HS,Wetchler BB, Blair MH, et al. Contemporary therapy of the menopausal syndrome[J]. JAMA, 1959, 171, 1627-1637.
  • 5Tan D, Haines CJ, Limpaphayom KK, et al. Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopasal Asian women from 11 countries:The Pan-Asia menopause(PAM) study[J].Maturitas, 2005, 52(1): 35-51.
  • 6Potts RO, Lobo RA. Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist[J].Obstet Gynecol, 2005, 105(5) : 953-961.
  • 7Jewelewicz R. New developments in topical estrogen therapy [J]. Fertil Steril, 1997, 67(1):1-12.
  • 8Delfin T, Christopher JH, Khunying KL, et al. Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopasal Asian women from 11 countries: The Pan-Asia menopause(PAM) study[J]. Maturitas, 2005, 52(1):35-51.
  • 9Utian WH, Shoupe D, Bachmann G, et al. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate[J].Fertil Steril,2001,75(6): 1065-1070.
  • 10Peeyananjarassri K, Baber R. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials[J]. Climacteric, 2005,8(1),13-23.

共引文献3

同被引文献29

  • 1王雪琼,周鸿敏,阎冀焕,袁劲,周洁,唐莉,陈忠华.雌激素对同种抗原刺激T细胞反应的影响[J].中国现代医学杂志,2006,16(6):829-832. 被引量:9
  • 2周志伟,莫海山,梁晖.肺癌患者血清白细胞介素6,8,18的测定及其临床意义[J].肿瘤研究与临床,2006,18(11):739-741. 被引量:9
  • 3夏贤,张绍芬,刘瑞梓,陆维仙,刘康达.雌二醇对去卵巢小鼠脾细胞雌激素受体表达和辅助性T细胞1和2平衡的影响[J].中华老年医学杂志,2007,26(5):379-382. 被引量:2
  • 4Takao T, Kumagai C, Hisakawa N, et al. Effect of 17beta-estradiol on tumor necrosis factor-alpha-induced cytotoxicity in the human peripheral T lymphocytes [J]. J Endocrinol,2005,184(1):191-197.
  • 5Dosiou C,Hamilton A E,Pang Y,et al. Expression of membrane pro- gesterone receptors on humanT lymphocytes and Jurkat cells and activation of G-proteins by progesterone[J]. J Endocrinol,2008,196 (1):67-77.
  • 6Zen M, Ghirardello A, laccarino L, et al. Hormones, immune re- sponse, and pregnancy in healthy women and SLE patients [J]. Swiss Med Wkly,2010,140(13-14):187-201.
  • 7Gameiro C M,Romo F,Castelo-Branco C. Menopause and aging: changes in the immune system-a review [J]. Maturitas, 2010,67 (4):316-320.
  • 8Quaedackets M E,Van Den Brink C E,Wissiwk S,et al. 4-hydroxy- tamoxifen trans-represses nuclear factor-KappaB activity in human osteoblastic U2-OS cells through estrogen receptor(ER) alpha, and not through ER beta[J]. Endocrinology, 2001, 142( 3 }: 1156-1166.
  • 9An J, Tzagarakis-Foster C, Scharschmidt T C, et al. Estrogen re- ceptor beta- selective transcriptional activity and recruitment of coregulators by phytoestrogens[J]. J Biol Chem, 2001, 276(21): 17808-17814.
  • 10Kanda N,Tamaki K. Estrogen enhances immunoglobulin pro- duction by human PBMCs[J]. J Allergy Clin Immunol,1999,103 (2ptl):282-288.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部